EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Effects of Intra-Articular versus Intravenous Mesenchymal Stromal Cells Therapy in a Rat Model of Osteoarthritis by Destabilization of Medial Meniscus

Felipe Bruno Dias de Oliveira, Eliane Antonioli, Olívia Furiama Metropolo Dias iD, Jean Gabriel de Souza, Sudha Agarwal, Ana Marisa Chudzinski-Tavassi, Mario Ferretti

International Journal of Molecular Sciences · 24.10.2023 · 24 (21) · 15543

DOI: 10.3390/ijms242115543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.10.2023. Verfasst von Felipe Bruno Dias de Oliveira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil. Hauptthemen laut MEDLINE: Osteoarthritis, Cartilage, Articular, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transplanted mesenchymal stromal cells (MSCs) exhibit a robust anti-inflammatory and homing capacity in response to high inflammatory signals, as observed in studies focused on rheumatic diseases that target articular cartilage (AC) health. However, AC degradation in osteoarthritis (OA) does not necessarily coincide with a highly inflammatory joint profile. Often, by the time patients seek medical attention, they already have damaged AC. In this study, we examined the therapeutic potential of a single bone marrow MSC transplant (2 × 106 cells/kgbw) through two different routes: intra-articular (MSCs-IAt) and intravenous (MSCs-IVt) in a preclinical model of low-grade inflammatory OA with an established AC degeneration. OA was induced through the destabilization of the medial meniscus (DMM) in female Wistar Kyoto rats. The animals received MSCs 9 weeks after surgery and were euthanized 4 and 12 weeks post-transplant. In vivo and ex vivo tracking of MSCs were analyzed via bioluminescence and imaging flow cytometry, respectively. Cytokine/chemokine modulation in serum and synovial fluid was measured using a multiplex panel. AC degeneration was quantified through histology, and hindlimb muscle balance was assessed with precision weighing. To our knowledge, we are the first group to show the in vivo (8 h) and ex vivo (12 h) homing of cells to the DMM–OA joint following MSCs-IVt. In the case of MSCs-IAt, the detection of cellular bioluminescence at the knee joint persisted for up to 1 week. Intriguingly, intra-articular saline injection (placebo-IAt) resulted in a worse prognosis of OA when compared to a non-invasive control (placebo-IVt) without joint injection. The systemic cytokines/chemokines profile exhibited a time-dependent variation between transplant routes, displaying a transient anti-inflammatory systemic response for both MSCs-IVt and MSCs-IAt. A single injection of MSCs, whether administered via the intra-articular or intravenous route, performed 9 weeks after DMM surgery, did not effectively inhibit AC degeneration when compared to a non-invasive control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisCartilage, ArticularMesenchymal Stem CellsMesenchymal Stem Cell TransplantationHumansRatsFemaleAnimalsMenisci, TibialAnti-Inflammatory AgentsInjections, Intra-Articular

Stichwörter der Autor:innen

inflammationintra-articularintravenousmesenchymal stem cellmesenchymal stromal cellosteoarthritis

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
  • Department of Biomedical Engineering, Wayne State University, Detroit, MI 48202, USA.
  • CENTD Centre of Excellence in New Target Discovery, Butantan Institute, São Paulo 05503-900, Brazil.
  • Division of Rheumatology and Immunology, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
  • Division of Biosciences, The Ohio State University College of Dentistry, Columbus, OH 43210, USA.
  • Laboratório de Desenvolvimento e Inovação, Butantan Institute, São Paulo 05503-900, Brazil.

ORCID-Profile: Olívia Furiama Metropolo Dias

Förderung

  • São Paulo Research Foundation
  • National Council for Scientific and Technological Development

Zitieren

APA

Dias de Oliveira, F. B., Antonioli, E., Dias, O. F. M., de Souza, J. G., Agarwal, S., Chudzinski-Tavassi, A. M., & Ferretti, M. (2023). Comparative Effects of Intra-Articular versus Intravenous Mesenchymal Stromal Cells Therapy in a Rat Model of Osteoarthritis by Destabilization of Medial Meniscus. International Journal of Molecular Sciences, 24(21), 15543. https://doi.org/10.3390/ijms242115543

Vancouver

Dias de Oliveira FB, Antonioli E, Dias OFM, de Souza JG, Agarwal S, Chudzinski-Tavassi AM, et al. Comparative Effects of Intra-Articular versus Intravenous Mesenchymal Stromal Cells Therapy in a Rat Model of Osteoarthritis by Destabilization of Medial Meniscus. International Journal of Molecular Sciences. 2023;24(21):15543. doi:10.3390/ijms242115543

BibTeX
@article{DiasdeOliveira2023,
  author = {Dias de Oliveira, Felipe Bruno and Antonioli, Eliane and Dias, Olívia Furiama Metropolo and de Souza, Jean Gabriel and Agarwal, Sudha and Chudzinski-Tavassi, Ana Marisa and Ferretti, Mario},
  title = {Comparative Effects of Intra-Articular versus Intravenous Mesenchymal Stromal Cells Therapy in a Rat Model of Osteoarthritis by Destabilization of Medial Meniscus},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {21},
  pages = {15543},
  doi = {10.3390/ijms242115543}
}
Kostenlos starten →